PMID

Data

Article Title

Organization

Perspectives on the Two-Pore Domain Potassium Channel TREK-1 (TWIK-Related K(+) Channel 1). A Novel Therapeutic Target?

Universit£

Potent and selective inhibitors of the TASK-1 potassium channel through chemical optimization of a bis-amide scaffold.

University of Kansas Specialized Chemistry Center

Ion channels as therapeutic targets: a drug discovery perspective.

Pfizer

Selective TASK-1 Inhibitor with a Defined Structure-Activity Relationship Reduces Cancer Cell Proliferation and Viability.

Centro De Estudios En Alimentos Procesados-Ceap

TASK Channels Pharmacology: New Challenges in Drug Design.

Universidad De Talca

Investigation of the binding determinants of phosphopeptides targeted to the SRC homology 2 domain of the signal transducer and activator of transcription 3. Development of a high-affinity peptide inhibitor.

The University of Texas At Houston

Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancer.

Abbott Laboratories